Enfusion Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Public

  • Employees
  • 1,102


  • Stock Symbol
  • ENFN

Stock Symbol

  • Share Price
  • $9.22
  • (As of Tuesday Closing)

Enfusion General Information


Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute an informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. It generates maximum revenue from Americas, followed by Asia Pacific and Europe, Middle East, and Africa.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Financial Software
Stock Exchange
Corporate Office
  • 125 South Clark Street
  • Suite 750
  • Chicago, IL 60603
  • United States
+1 (312) 000-0000

Enfusion Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enfusion Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$9.22 $9.38 $7.52 - $11.56 $847M 91.9M 424K $0.03

Enfusion Financials Summary

In Thousands,
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 834,957 863,696 645,593 1,632,283
Revenue 181,616 174,535 150,349 111,700
EBITDA 16,309 19,830 (6,258) (273,094)
Net Income 2,541 6,025 (7,654) (158,317)
Total Assets 110,963 108,972 123,783 106,085
Total Debt 15,460 15,437 6,989 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Enfusion Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Enfusion‘s full profile, request access.

Request a free trial

Enfusion Comparisons

HQ Location
Total Raised
Post Valuation
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its
Financial Software
Chicago, IL
1,102 As of 2023
00.000 0000-00-00
00000000 00000


am, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo cons
000000000 00000000
Paris, France
000 As of 0000
00.00 0000-00-00


ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate vel
000000000 00000000
Princeton, NJ
00 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enfusion Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
eFront Formerly PE-Backed Paris, France 000 00.000 000000&0
Kinetix Trading Solutions Corporation Princeton, NJ 00
Allvue Systems Private Equity-Backed Coral Gables, FL 000 00000 000000000 00000
ION Group Private Equity-Backed London, United Kingdom 0000 000.00 000000000 00 000.00
NeoXam Private Equity-Backed Paris, France 000 000000000000
You’re viewing 5 of 31 competitors. Get the full list »

Enfusion Executive Team (21)

Name Title Board Seat Contact Info
Bradley Herring Chief Financial Officer
Neal Pawar Chief Operating Officer, Operations
Scott Werner Managing Partner
Stephen Malherbe Managing Partner
Valeria Gutowski Chief Accounting Officer, Accounting
You’re viewing 5 of 21 executive team members. Get the full list »

Enfusion Board Members (10)

Name Representing Role Since
00000000 000000000 FTV Capital Board Member 000 0000
0000000 000000 Self Board Member 000 0000
000 000000 Self Board Member 000 0000
00000000 000000 Self Board Member 000 0000
00000000 000000000 Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Enfusion Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enfusion Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Enfusion‘s full profile, request access.

Request a free trial

Enfusion ESG

Risk Overview

Risk Rating

Updated February, 23, 2023

23.12 | Med Risk

Risk Scale

A lower score indicates better sustainability












Exposure refers to the extent to which a company is exposed to different material ESG issues



Management is related to actions taken to manage ESG issues


Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.


Covered Companies

00 of 16,421




Software & Services


00 of 1,116




Enterprise and Infrastructure Software


00 of 451




To view Enfusion’s complete esg history, request access »

Enfusion FAQs

  • When was Enfusion founded?

    Enfusion was founded in 1995.

  • Who is the CEO of Enfusion?

    Oleg Movchan is the CEO of Enfusion.

  • Where is Enfusion headquartered?

    Enfusion is headquartered in Chicago, IL.

  • What is the size of Enfusion?

    Enfusion has 1,102 total employees.

  • What industry is Enfusion in?

    Enfusion’s primary industry is Financial Software.

  • Is Enfusion a private or public company?

    Enfusion is a Public company.

  • What is Enfusion’s stock symbol?

    The ticker symbol for Enfusion is ENFN.

  • What is the current stock price of Enfusion?

    As of 21-May-2024 the stock price of Enfusion is $9.22.

  • What is the current market cap of Enfusion?

    The current market capitalization of Enfusion is $847M.

  • What is Enfusion’s current revenue?

    The trailing twelve month revenue for Enfusion is $182M.

  • Who are Enfusion’s competitors?

    eFront, Kinetix Trading Solutions, Allvue Systems, ION Group, and NeoXam are some of the 31 competitors of Enfusion.

  • What is Enfusion’s annual earnings per share (EPS)?

    Enfusion’s EPS for 12 months was $0.03.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »